Goldman Sachs’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.79M | Buy |
|
|||||
|
2025
Q1 | $1.33M | Sell |
|
|||||
|
2024
Q4 | $4.54M | Buy |
|
|||||
|
2024
Q3 | $2.21M | Buy |
|
|||||
|
2024
Q2 | $1.08M | Sell |
|
|||||
|
2024
Q1 | $5.11M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $15K | Sell |
|
|||||
|
2022
Q3 | $158K | Sell |
|
|||||
|
2022
Q2 | $147K | Sell |
|
|||||
|
2022
Q1 | $470K | Sell |
|
|||||
|
2021
Q4 | $829K | Buy |
|
|||||
|
2021
Q3 | $1.25M | Buy |
|
|||||
|
2021
Q2 | $1.5M | Buy |
|
|||||
|
2021
Q1 | $730K | Sell |
|
|||||
|
2020
Q4 | $608K | Sell |
|
|||||
|
2020
Q3 | $641K | Buy |
|
|||||
|
2020
Q2 | $578K | Buy |
|
|||||
|
2020
Q1 | $269K | Buy |
|
|||||
|
2019
Q4 | $339K | Buy |
|
|||||
|
2019
Q3 | $226K | Sell |
|
|||||
|
2019
Q2 | $358K | Sell |
|
|||||
|
2019
Q1 | $461K | Buy |
|
|||||
|
2018
Q4 | $105K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.02M | Buy |
|